Navigation Links
Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India
Date:10/28/2009

ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that CPL Biologicals Pvt. Ltd., the new joint venture between Cadila Pharmaceuticals in India, has begun construction of a state-of-the-art manufacturing facility that will be used to produce pandemic and seasonal influenza vaccines. CPL Biologicals will utilize Novavax's virus-like particle (VLP) vaccine technology to produce commercial-scale quantities of VLP-based influenza vaccines using Novavax's innovative disposable manufacturing solution. The CPL Biologicals facility is expected to be operational within four months and should be capable of producing over 60 million doses annually at full capacity. This facility will also be used to produce other novel vaccines being developed by CPL Biologicals, based on Novavax's VLP vaccine technology.

"This new facility is being 100% supported financially by our partner, Cadila Pharmaceuticals Ltd. We anticipate creating sufficient capacity for CPL Biologicals to sell influenza vaccines in India and at the same time become a potential supplier to Novavax for sale of vaccines in other markets where Novavax maintains complete commercial rights," commented John Trizzino, Senior Vice President, International and Government Alliances for Novavax and Interim Chief Executive Officer of CPL Biologicals. "We believe this model will show how an efficient and scalable vaccine platform can help address the growing demand for pandemic and seasonal influenza vaccines. Moreover, the construction of this manufacturing facility is consistent with Novavax's strategy to establish regional partnerships and regional manufacturing capabilities that allow our VLP influenza vaccines to be licensed, manufactured and sold throughout the world."

About VLPs

Virus-like particles (VLPs) mimic the
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Novavax Awarded NIH Grant for Respiratory Syncytial Virus (RSV) Vaccine Program
2. Novavax CEO to Present at the World Vaccine Congress 2009, Lyon, France
3. Novavax Announces Board of Director Changes
4. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
5. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
6. Novavax Reports Second Quarter 2009 Financial Results
7. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
8. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
9. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
10. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
11. Novavax Announces Repayment of $5 Million of Convertible Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Gene Specific siRNA Controls , ... in siRNA , research or you ... convenience of the Silencer gene specific siRNA , ... contains 50 g of ready-to-use chemically synthesized and gel , ...
... , experiment depends ... expression vehicles (plasmids, PCR fragments) into cells. Many , ... reagents to deliver ... cells. The choice of reagent and the conditions under which it , ...
... Fluorescence activated cell sorting (FACS) is a , ... , individual cells using fluorescent probes that bind specifically ... is commonly used to collect , cells of a ... , Figure 1.Linear Amplification from 1-1000 Cells. ...
Cached Biology Technology:Control Your siRNA Research 2Control Your siRNA Research 3Choose the Right Transfection Agent for Your RNAi Experiment 2Choose the Right Transfection Agent for Your RNAi Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 4Choose the Right Transfection Agent for Your RNAi Experiment 5Choose the Right Transfection Agent for Your RNAi Experiment 6Choose the Right Transfection Agent for Your RNAi Experiment 7Cells-to-cDNA II Using FACS Sorted Cells 2
(Date:4/15/2014)... Reserve University dental researchers have found a less ... from the mouth to study how the mouth,s ... By isolating some specialized immune cells (white blood ... fight diseases in the mouthor reject foreign tissues, ... learn more about treating and preventing such health ...
(Date:4/15/2014)... form could help reduce side effects by targeting the ... have developed nanoparticles that deliver one or two chemotherapy ... particles that can carry any more than that in ... a new way to build such nanoparticles, making it ... In a paper published in the Journal of ...
(Date:4/15/2014)... By 2050, deforestation could cause temperatures in the ... increase would intensify warming caused by greenhouse gases ... at the University of Leuven, Belgium. , Explosive ... large-scale destruction of tropical rainforests in Central Africa. ... Leuven examined how these practices will affect longer-term ...
Breaking Biology News(10 mins):New method isolates immune cells for researchers to study how they ward off oral diseases 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Study: Deforestation could intensify climate change in Congo Basin by half 2
... finger as hard as you can against the surface. Now ... follow the ticking clock. Now faster. Now faster." These ... casts doubt on old ideas about mechanisms to control hand ... manual dexterity is so vulnerable to aging and disease, and ...
... developed salt-tolerant plants using a new type of genetic modification ... The research team based at the University of ... GM technique to contain salt in parts of the plant ... which means the results of this research could impact on ...
... 7, 2009) -- The Wildlife Conservation Society (WCS) announced today ... of the Amazon in Brazil. The monkey is related to ... their distinctively marked backs. The newly described distinct subspecies ... the state of Amazonas in northwestern Brazil. The discovery was ...
Cached Biology News:1-finger exercise reveals unexpected limits to dexterity 21-finger exercise reveals unexpected limits to dexterity 3Scientists closer to developing salt-tolerant crops 2New monkey discovered in Brazil 2
Request Info...
... Freezer Inventory Storage Racks for Standard ... to fit all makes and models ... Made of high quality stainless steel ... fiberboard, stainless steel or plastic boxes. ...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Chlorine-36, 3.7 MBq, 100 uCi. 0.1-0.3 HCl.< 111 MBq/g Cl, < 3 mCi/g Cl.Dispensed to order. Please inquire for alternative pack sizes. Category: Radiochemicals &Radiation Safety, Radiochemicals....
Biology Products: